Laxxon Medical to Participate in 22nd Annual Needham Virtual Healthcare Conference

2023-04-17

NEW YORK, NY / ACCESSWIRE / April 17, 2023 / Laxxon Medical announced today their participation in the 22nd Annual Needham Virtual Healthcare Conference from Monday, April 17th to Thursday, April 20th. Laxxon CEO Helmut Kerschbaumer will present on Thursday, April 20th at 9:30A.M. ET. The live webcast link can be accessed on the "Investors" page at . A replay of the webcast will be available on the Laxxon website following the presentation. About Laxxon Medical Corporation Laxxon Medical is a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for the development, manufacture, and commercialization of pharmaceutical dosage forms. For more information, visit or follow Laxxon Medical on LinkedIn or Twitter. Investor Contact: Frances Hoggard Communications Manager f.hoggard@laxxonmedical.com SOURCE: Laxxon Medical View source version on accesswire.com:

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

Laxxon Medical GmbH